OVARIAN

Clinical trials for OVARIAN explained in plain language.

Never miss a new study

Get alerted when new OVARIAN trials appear

Sign up with your email to follow new studies for OVARIAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo shows promise in controlling advanced cancers

Disease control Ongoing

This study tests a combination of two drugs, MEDI4736 (an immunotherapy) and olaparib (a targeted therapy), in people with advanced solid tumors like ovarian, breast, lung, and stomach cancers. The goal is to see if the combo can shrink or stabilize tumors. About 264 participants…

Matched conditions: OVARIAN

Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control

Last updated May 15, 2026 11:56 UTC

OVARIAN

Get alerted when new OVARIAN trials appear

New drug combo shows promise in controlling advanced cancers